Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. PATH and Washington State University have been closely tracking viruses with the most potential to cause an outbreak. PATH’s Director of Epidemic Preparedness and Response, Linda Venczel, speaks to Seattle KING 5 on PATH’s epidemic response
    Published: March 2023
  2. Kiersten Israel-Ballard, Team Lead of PATH’s Maternal, Newborn, Child Health, and Nutrition program, speaks with National Geographic about PATH’s work developing breastfeeding programs in Kenya, India, South Africa, and Vietnam.
    Published: January 2023
  3. In the Hindustan Times, PATH president and CEO Nikolaj Gilbert takes a closer look at India's people-centric, sustainable, and future-ready health systems.
    Published: January 2023
  4. PATH is proud to have been listed as one of Forbes' Top 100 Charities in the United States.
    Published: December 2022

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release